Archived explainer. For the current picture see today's ALHC page.
ALIGNMENT HEALTHCARE (ALHC) is up +3.81% in the latest session. Our newswire has captured 1 story on ALHC across 1 source in the last 36 hours, with AI sentiment reading bearish (avg 34/100).
Alignment Healthcare (ALHC) shares rose 3.81% to $13.91 in morning trading on Wednesday. The stock’s move followed a recent update to guidance and ongoing coverage from major financial firms. Despite a wave of downgrades and price target cuts, the stock opened higher and has traded near its session high for much of the session.
The stock opened at $13.44 and climbed steadily throughout the morning. A key catalyst was the company’s raised full-year 2026 revenue guidance, which now stands at $5.195B to $5.225B, exceeding the $5.189B estimate. This update was announced in the background headlines and signals stronger-than-expected performance. However, the stock has faced pressure from recent analyst actions. JP Morgan and Raymond James both cut their price targets, with JP Morgan lowering it to $22 and Raymond James to $19. Despite these moves, the stock remains above its 52-week low of $12.70 and has gained 5.6% over the past eight sessions.
Kaplan Fox, a law firm, announced an investigation into potential securities law violations at Alignment Healthcare, which may have contributed to investor uncertainty. Meanwhile, several insiders have sold shares recently, including the CEO and president, according to SEC filings. These sales totaled $23.4 million in the last 90 days, with no insider purchases reported.
The stock’s intraday performance shows a strong start, with a high of $13.93 reached at 9:55 AM ET. Volume so far is 0.2 million shares, which is in line with the 3-month average. The stock is currently trading within its 52-week range and has printed 13 fresh 52-week highs on September 1, 2026. The market cap is $2.8 billion, with a P/E ratio of 67.8 and a net margin of 0.9%. The stock’s beta of 1.13 indicates it is slightly more volatile than the broader market.
Investors should monitor the company’s performance against its updated guidance and any further analyst activity. No earnings date is provided, but continued coverage from major firms could influence the stock’s trajectory.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
Kaplan Fox is investigating potential securities law violations at Alignment Healthcare, Inc. (NASDAQ: ALHC) on behalf of investors....
More on ALHC: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.
Earlier ALHC move explainers: 2026-09-09 · 2026-09-01 · 2026-08-26 · 2026-07-31